Second international guidelines for the diagnosis and management of hereditary hemorrhagic telangiectasia
Ann. intern. med; 173 (12), 2020
Hereditary hemorrhagic telangiectasia (HHT) is an autosomal dominant disease with an estimated prevalence of 1 in 5000 that is characterized by the presence of vascular malformations (VMs). These result in chronic bleeding, acute hemorrhage, and complications from shunting through VMs. The goal of the Se...